1. From: Meta-analysis: β-Blocker Dose, Heart Rate Reduction, and Death in Patients With Heart Failure
Ann Intern Med. 2009;150(11): doi: /
Figure Legend:
Study flow diagram.
Date of download: 11/7/2017
Copyright © American College of Physicians. All rights reserved.

2. From: Meta-analysis: β-Blocker Dose, Heart Rate Reduction, and Death in Patients With Heart Failure
Ann Intern Med. 2009;150(11): doi: /
Figure Legend:
All-cause mortality in trials of 50 or more patients, by agent.Trial acronyms are defined in Table 1. NA = not applicable; RR = risk ratio.
Date of download: 11/7/2017
Copyright © American College of Physicians. All rights reserved.

3. From: Meta-analysis: β-Blocker Dose, Heart Rate Reduction, and Death in Patients With Heart Failure
Ann Intern Med. 2009;150(11): doi: /
Figure Legend:
All-cause mortality, by treatment-related HR reduction tertile.Trial acronyms are defined in Table 1. HR = heart rate; RR = risk ratio.
Date of download: 11/7/2017
Copyright © American College of Physicians. All rights reserved.

4. From: Meta-analysis: β-Blocker Dose, Heart Rate Reduction, and Death in Patients With Heart Failure
Ann Intern Med. 2009;150(11): doi: /
Figure Legend:
Meta-regression line for magnitude of heart rate reduction and risk ratio of all-cause mortality.The mortality logarithm of relative risk is plotted against the reduction in heart rate. Circles are the observed estimates; size is based on the inverse of the SE of each trial. The 3 lines are the fitted and the upper and lower bounds of the 95% CIs.
Date of download: 11/7/2017
Copyright © American College of Physicians. All rights reserved.